Phio Pharmaceuticals
PHIO
3 hedge funds and large institutions have $3.06M invested in Phio Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
19% less capital invested
Capital invested by funds: $3.78M → $3.06M (-$728K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BW
Bison Wealth
Atlanta,
Georgia
|
-$13K |
| 2 |
Jane Street
New York
|
-$5K |
PHIO Hedge Fund Activity: Q3 2015 in Review
3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q3 2015, worth a combined $3.06M — down 19% from $3.78M a quarter earlier.
Fund positioning in PHIO was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Bison Wealth, cutting an estimated $13K.
- 3 institutional investors held Phio Pharmaceuticals (PHIO) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $3.06M of Phio Pharmaceuticals stock for Q3 2015, down 19% quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals positions in Q3 2015 and 0 closed out.
- The largest Phio Pharmaceuticals seller in Q3 2015 was Bison Wealth, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2015.